Back to All Events

March 21, 2019

Zealand Pharma R&D Update, Conference Call

Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR no. 20 04 50 78) will host a conference call on March 21, 2019 at 4 pm CET/10 am EST to provide updated information relating to R&D and business activities.

Interim Chief Executive Officer Adam Steensberg and Chief Science Officer Andrew Parker will present, with the corporate management team in attendance. The presentation will be followed by a Q&A session. The conference call will be conducted in English, and the dial-in numbers are:

Denmark:..................... +45 32 72 80 42
United Kingdom:.......... +44 (0) 844 571 8892
United States:.............. +1 631 510 7495
Passcode..................... 4249418

A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/m6/p/593xy77b, and will be accessible on the Investor section of Zealand’s website (www.zealandpharma.com). Participants are advised to register for the webcast approximately 10 minutes before the scheduled start. A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call.

Earlier Event: March 14
March 14, 2019
Later Event: April 9
April 9-10, 2019